LDLR and Hypercholesterolemia: It is of interest to mention that transgenic mice with high levels of soluble endoglin on any atherosclerotic background (apoE-deficient, LDLR-deficient) are not available and thus we cannot evaluate whether high levels of soluble endoglin might contribute to endothelial dysfunction in atherosclerosis where hypercholesterolemia and inflammation are also present.